ARCHIVES

FDA Committee Okays Carboplatin For Second Line Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 15 No. 01 | January 6, 1989

Download PDF Visit The Full Archive

Related Articles

News Analysis: IOM Report A Case Study In Communications Disaster

February 5, 1999

Tamoxifen Makes ER-Negative Breast Cancer Easier To Find

October 31, 2008

In Brief: AMA Opposes Bill To Permit Heroin Use For Pain Control, Says Morphine Is Equally As Effective

March 23, 1984

NCI Health Disparities Center Describes “Think Tank” Projects For Policy Change.

April 27, 2001

Three cancer societies to be led by Vanderbilt faculty in 2004

July 18, 2003

FDA to Move Away From Central Radiology To Investigator Review In PFS Endpoint Trials

July 27, 2012